[en] Daunomycin is a potent inducer of p53 and NF-kappaB transcription factors. It is also able to increase the amount of the p21 cyclin-dependent kinase inhibitor. The human p21 promoter harbors p53-responsive elements and an NF-kappaB binding site.
Baldwin A.S.J., Azizkhan J.C., Jensen D.E., Beg A.A., Coodly L.R. (1991) Induction of NF-kappaB DNA-binding activity during the G0-to-G1 transition in mouse fibroblasts. Mol Cell Biol 11:4943-4951.
Bash J., Zong W.-X., Gelinas C. (1997) c-Rel arrests the proliferation of Hela cells and affects critical regulators of the G1/S-phase transition. Mol Cell Biol 17:6526-6536.
Beg A.A., Baltimore D. (1996) An essential role for NF-κB in preventing TNF-α-induced cell death. Science (Wash DC) 274:782-784.
Bentires-Alj M., Hellin A.C., Ameyar M., Chouaib S., Merville M.P., Bours V. (1999) Stable inhibition of nuclear factor kappaB in cancer cells does not increase sensitivity to cytotoxic drugs. Cancer Res 59:811-815.
Billon N., Van Grunsven L.A., Rudkin B.B. (1996) The CDK inhibitor p21WAF1/ Cip1 is induced through a p300-dependent mechanism during NGF-mediated neuronal differentiation of PC12 cells. Oncogene 13:2047-2054.
Boland M.P., Foster S.J., O'Neill L.A.J. (1997) Daunorubicin activates NFκB and induces κB-dependent gene expression in HL-60 promyelocytic and Jurkat T lymphoma cells. J Biol Chem 272:12952-12960.
Bonizzi G., Piette J., Merville M.-P., Bours V. (1997) Distinct signal transduction pathways mediate nuclear factor-κB induction by IL-1β in epithelial and lymphoid cells. J Immunol 159:5264-5272.
Bours V., Burd P.R., Brown K., Villalobos J., Park S., Ryseck R.-P., Bravo R., Kelly K., Siebenlist U. (1992) A novel mitogen-inducible gene product related to p50/p105-NF-κB partipates in transactivation through a κB site. Mol Cell Biol 12:685-695.
Cai Z., Capoulade C., Moyret-Lalle C., Amor-Gueret M., Feunteun J., Larsen A.K., Paillerets B.B., Chouaib S. (1997) Resistance of MCF7 human breast carcinoma cells to TNF-induced cell death is associated with loss of p53 function. Oncogene 15:2817-2826.
Cai Z., Korner M., Tarantino N., Chouaib S. (1997) IκBα overexpression in human breast carcinoma MCF7 cells inhibits nuclear factor-κB activation but not tumor necrosis factor-α-induced apoptosis. J Biol Chem 272:96-101.
El-Deiry W.S., Harper J.W., O'Connor P.M., Velculescu V.E., Canman C.E., Jackman J., Pietenpol J.E., Burrell M., Hill D.E., Wang Y., Wiman K.G., Mercer W.E., Kastan M.B., Kohn K.W., Elledge S.J., Kinzler K.W., Vogelstein B. (1994) WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 54:1169-1174.
El-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer W.E., Kinzler K.W., Vogelstein B. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
El-Deiry W.S., Tokino T., Waldman T., Oliner J.D., Velculescu V.E., Burrell M., Hill D.E., Healy E., Rees J.L., Hamilton S.R. (1995) Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res 55:2910-2919.
Fritsche M., Haessler C., Brandner G. (1993) Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene 8:307-318.
Ghosh S., May M.J., Kopp E.B. (1998) NF-κB and Rel proteins: Evolutionary conserved mediators of immune responses. Annu Rev Immunol 16:225-260.
Grilli M., Pizzi M., Memo M., Spano P. (1996) Neuroprotection of aspirin and sodium salicylate through blockade of NF-κB activation. Science (Wash DC) 274:1383-1385.
Guttridge D.C., Albanese C., Reuther J.Y., Pestell R.G., Baldwin A.S. Jr. (1999) NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol Cell Biol 19:5785-5799.
Haapajarvi T., Kivinen L., Heiskanen A., Des Bordes C., Datto M.B., Wang X.F., Laiho M. (1999) UV radiation is a transcriptional inducer of p21(Cip1/Waf1) cyclin-kinase inhibitor in a p53-independent manner. Exp Cell Res 248:272-279.
Hainaut P., Rolley N., Davies M., Milner J. (1995) Modulation by copper of p53 conformation and sequence-specific DNA binding: Role for Cu(II)/Cu(I) redox mechanism. Oncogene 10:27-32.
Hirano Y., Yamato K., Tsuchida N. (1995) A temperature sensitive mutant of the human p53, Val138, arrests rat cell growth without induced expression of cip1/ waf1/sdi1 after temperature shift-down. Oncogene 10:1879-1885.
Lin K.I., Lee S.H., Narayanan R., Baraban J.M., Hardwick J.M., Ratan R.R. (1995) Thiol agents and bcl-2 identity an alphavirus-induced apoptotic pathway that requires activation of the transcription factor NF-kB. J Biol Chem 131:1149-1161.
Macleod K.F., Sherry N., Hannon G., Beach D., Tokino T., Kinzler K., Vogelstein B., Jacks T. (1995) p53-Dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev 9:935-944.
Michieli P., Chedid M., Lin D., Pierce J.H., Mercer W.E., Givol D. (1994) Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res 54:3391-3395.
Perkins N.D., Felzien L.K., Betts J.C., Leung K., Beach D.H., Nabel G.J. (1997) Regulation of NF-κB by cyclin-dependent kinases associated with the p300 coactivator. Science (Wash DC) 275:523-527.
Peter M., Herskowitz I. (1994) Joining the complex: Cyclin-dependent kinase inhibitory proteins and the cell cycle. Cell 79:181-184.
Powis G. (1987) Metabolism and reactions of quinoid anticancer agents. Pharmacol Ther 35:57-162.
Qiu X., Forman H.J., Schonthal A.H., Cadenas E. (1921) Induction of p21 mediated by reactive oxygen species formed during the metabolism of aziridinyl-benzoquinones by HCT116 cells. J Biol Chem 271:31915-31921.
Ravi R., Mookerjee B., Van Hensbergen Y., Bedi G.C., Giordano A., El-Deiry W.S., Fuchs E.J., Bedi A. (1998) p53-Mediated repression of nuclear factor-kappaB RelA via the transcriptional integrator p300. Cancer Res 58:4531-4536.
Russo T., Zambrano N., Esposito F., Ammendola R., Cimino F., Fiscella M., Jackman J., O'Connor P.M., Anderson C.W., Appella E. (1995) A p53-independent pathway for activation of WAF1/CIP1 expression following oxidative stress. J Biol Chem 270:29386-29391.
Ryan K.M., Ernst M.K., Rice N.R., Vousden K.H. (2000) Role of NF-kappaB in p53-mediated programmed cell death. Nature (Lond) 404:892-897.
Scheffner M., Werness B.A., Huibregtse J.M., Levine A.J., Howley P.M. (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129-1136.
Schreck R., Meier B., Mannel D.N., Droge W., Baeuerle P.A. (1992) Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J Exp Med 175:1181-1194.
Sheehy A.M., Schlissel M.S. (1999) Overexpression of RelA causes G1 arrest and apoptosis in a pro-B cell line. J Biol Chem 274:8708-8716.
Tewey K.M., Rowe T.C., Yang L., Halligan B.D., Liu L.F. (1984) Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. Science (Wash DC) 226:466-468.
Van Antwerp D.J., Martin S.J., Kafri T., Green D.R., Verma I.M. (1996) Suppression of TNF-α-induced apoptosis by NF-κB. Science (Wash DC) 274:787-789.
Wadgaonkar R., Phelps K.M., Haque Z., Williams A.J., Silverman E.S., Collins T. (1999) CREB-binding protein is a nuclear integrator of nuclear factor-kappaB and p53 signaling. J Biol Chem 274:1879-1882.
Wang C.Y., Cusack J.C. Jr., Liu R., Baldwin A.S. Jr. (1999) Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB. Nat Med 5:412-417.
Wang C.-Y., Mayo M.W., Baldwin A.S. (1996) TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB. Science (Wash DC) 274:784-787.
Xiong Y., Hannon G.J., Zhang H., Casso D., Kobayashi R., Beach D. (1993) p21 is a universal inhibitor of cyclin kinases. Nature (Lond) 366:701-704.
Zhang H., Xiong Y., Beach D. (1993) Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes. Mol Biol Cell 4:897-906.
